Project Grant R01NS064494

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $411,941 to Drexel University to conduct research on identifying novel trunk reflex pathways and how they differ after neonatal versus adult spinal cord injury in animal models. The key objectives are to test the hypothesis that the newly discovered contralateral monosynaptic trunk...

The Department of the Army Medical Command awarded a $1.5 million Project Grant to the University of Miami to support research on the "Safety and Efficacy of Autologous Human Schwann Cell (AHSC) Augmentation in Severe Peripheral Nerve Injury (PNI)." The grant period runs from September 30, 2022 to September 29, 2026. The research aims to investigate using a patient's own Schwann cells, which support nerve growth, to treat severe injuries to peripheral nerves. This work aligns with...

This $424,875.00 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund a comprehensive study of gene transcription patterns in diverse classes of neurons that connect the brain to the spinal cord after spinal cord injury in a mouse model. The research team at Marquette University will use single-cell sequencing technologies to profile...

Federal Project Grant Award Summary Temple University received a $566,382 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded August 15, 2025, with completion targeted by July 31, 2030. The grant funds research focused on modality-specific restoration of somatosensory connections following dorsal root injury, a condition that causes permanent...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $437,250 to the University of California, San Diego (UCSD) to conduct pooled in vivo screening of combination gene therapies for enhancing axonal regeneration after spinal cord injury (SCI). The key objectives are to 1) perform CRISPR screening to identify the most effective...

Federal Grant Award Summary The University of Washington, Seattle, WA received a $427,625 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective May 21, 2025, with a completion date of April 30, 2027. The research project investigates whether electrical stimulation (ES) enhances the therapeutic capacity of neural stem cell (NSC) transplants...

Federal Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded Shirley Ryan AbilityLab a $2.86 million Project Grant (CFDA 93.865 – Child Health and Human Development Extramural Research) effective September 1, 2025, through August 31, 2028, to conduct research on paired stimulation plasticity for motor recovery in cervical spinal cord injury (SCI). The research project investigates two innovative neural stimulation...

Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded New Jersey Institute of Technology $553,292 on March 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This three-year project grant, concluding February 28, 2029, supports the development of an in vitro three-dimensional (3D) tissue construct system to study peripheral nerve regeneration and axonal growth. The...

The National Institute of Neurological Disorders and Stroke (NINDS), through the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), awarded Versapeutics Inc. a $2,380,552 federal project grant on September 18, 2023 to conduct toxicology and efficacy studies of their novel antibody therapeutic Versamab-101 for treating spinal cord injury. Versapeutics, a for-profit biotechnology company, will utilize the funding to evaluate the safety profile and determine...

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $6,522,833 Project Grant to The Leland Stanford Junior University to conduct a mechanistic randomized clinical trial investigating the central and peripheral nervous system mechanisms of pain relief induced by peripheral nerve stimulation (PNS) for the treatment of refractory chronic neuropathic pain. The 3-year study, funded under the NIH HEAL Initiative's CFDA 93.279 Drug Abuse and Addiction Research Programs, aims...